Omicron variant BA.4.6 evades protection of Evusheld's antibodies, study finds

New Omicron offshoot BA.4.6 evades protection of Evusheld's antibodies, study finds The antibodies in Evusheld, the only therapy available to protect people with reduced immune function against Covid-19, may lose their punch against the BA.4.6 subvariant, a new study shows. Brenda Goodman, CNN CNN

...

This vital therapy has been holding up well against new coronavirus variants. But in new tests, Dr. David Ho, a professor of microbiology and immunology at Columbia University, found that although this subvariant doesn't seem to bind to our cells more easily than others, it does appear to evade the ability of some antibodies to neutralize it, including those in Evusheld.

...